129 related articles for article (PubMed ID: 11422411)
1. Hydroxyurea and periodicity in myeloproliferative disease.
Bennett M; Grunwald AJ
Eur J Haematol; 2001 May; 66(5):317-23. PubMed ID: 11422411
[TBL] [Abstract][Full Text] [Related]
2. Chronic myeloid leukaemia with marked thrombocytosis in a patient with thalassaemia major: complete haematological remission under the combination of hydroxyurea and anagrelide.
Voskaridou E; Terpos E; Komninaka V; Eftyhiadis E; Mantzourani M; Loukopoulos D
Br J Haematol; 2002 Jan; 116(1):155-7. PubMed ID: 11841409
[TBL] [Abstract][Full Text] [Related]
3. Cyclic oscillations of leucocyte counts in chronic myeloid leukaemia.
Malhotra OP; Salam SR
Postgrad Med J; 1991 Jan; 67(783):87-9. PubMed ID: 2057439
[TBL] [Abstract][Full Text] [Related]
4. Periodic chronic myelogenous leukaemia: spectral analysis of blood cell counts and aetiological implications.
Fortin P; Mackey MC
Br J Haematol; 1999 Feb; 104(2):336-45. PubMed ID: 10050717
[TBL] [Abstract][Full Text] [Related]
5. Anagrelide for treatment of patients with chronic myelogenous leukemia and a high platelet count.
Trapp OM; Beykirch MK; Petrides PE
Blood Cells Mol Dis; 1998 Mar; 24(1):9-13. PubMed ID: 9516377
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of alpha interferon and hydroxyurea in late phase refractory myeloproliferative disease.
Litam PP; Landaw SA; Zamkoff KW
Haematologia (Budap); 1994; 26(2):87-90. PubMed ID: 7890266
[TBL] [Abstract][Full Text] [Related]
7. Hydroxyurea versus busulphan for chronic myeloid leukaemia: an individual patient data meta-analysis of three randomized trials. Chronic myeloid leukemia trialists' collaborative group.
Br J Haematol; 2000 Sep; 110(3):573-6. PubMed ID: 10997966
[TBL] [Abstract][Full Text] [Related]
8. Anagrelide is effective in treating patients with hydroxyurea-resistant thrombocytosis in patients with chronic myeloid leukemia.
Silver RT
Leukemia; 2005 Jan; 19(1):39-43. PubMed ID: 15510207
[TBL] [Abstract][Full Text] [Related]
9. Elevated white blood cell synthesis of leukotriene C4 in chronic myelogenous leukaemia but not in polycythaemia vera.
Stenke L; Samuelsson J; Palmblad J; Dabrowski L; Reizenstein P; Lindgren JA
Br J Haematol; 1990 Mar; 74(3):257-63. PubMed ID: 2110464
[TBL] [Abstract][Full Text] [Related]
10. Leg ulcers associated with long-term hydroxyurea therapy.
Weinlich G; Schuler G; Greil R; Kofler H; Fritsch P
J Am Acad Dermatol; 1998 Aug; 39(2 Pt 2):372-4. PubMed ID: 9703157
[TBL] [Abstract][Full Text] [Related]
11. [Hydroxyurea-induced leg ulcers in patients with chronic myeloproliferative disorders].
Olesen LH; Pedersen BB
Ugeskr Laeger; 2001 Dec; 163(49):6908-11. PubMed ID: 11766504
[TBL] [Abstract][Full Text] [Related]
12. Hydroxyurea-associated platelet count oscillations in polycythemia vera: a report of four new cases and a review.
Steensma DP; Harrison CN; Tefferi A
Leuk Lymphoma; 2001; 42(6):1243-53. PubMed ID: 11911405
[TBL] [Abstract][Full Text] [Related]
13. Hydroxycarbamide associated platelet count oscillations in a patient with polycythaemia vera. A case report and review of the literature.
Burthem J; Chaudhry MS
Platelets; 2008 May; 19(3):234-5. PubMed ID: 18432524
[TBL] [Abstract][Full Text] [Related]
14. Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management.
Tefferi A
Am J Hematol; 2012 Mar; 87(3):285-93. PubMed ID: 22331582
[TBL] [Abstract][Full Text] [Related]
15. Treatment paradigms in the management of myeloproliferative disorders.
Fruchtman SM
Semin Hematol; 2004 Apr; 41(2 Suppl 3):18-22. PubMed ID: 15190519
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and treatment of polycythemia vera and possible future study designs of the PVSG.
Michiels JJ; Barbui T; Finazzi G; Fuchtman SM; Kutti J; Rain JD; Silver RT; Tefferi A; Thiele J
Leuk Lymphoma; 2000 Jan; 36(3-4):239-53. PubMed ID: 10674896
[TBL] [Abstract][Full Text] [Related]
17. Polycythaemia vera: bone marrow histopathology under treatment with interferon, hydroxyurea and busulphan.
Kreft A; Nolde C; Büsche G; Buhr T; Kreipe H; Georgii A
Eur J Haematol; 2000 Jan; 64(1):32-41. PubMed ID: 10680703
[TBL] [Abstract][Full Text] [Related]
18. Severe hypersensitivity pneumonitis associated with anagrelide.
Raghavan M; Mazer MA; Brink DJ
Ann Pharmacother; 2003 Sep; 37(9):1228-31. PubMed ID: 12921504
[TBL] [Abstract][Full Text] [Related]
19. Perimalleolar ulcers in hydroxyurea treated patients with concomitant chronic venous disease: diagnostic pitfalls.
Jain V; Gupta K; Nagpal N
J Coll Physicians Surg Pak; 2005 Oct; 15(10):658-60. PubMed ID: 19810313
[TBL] [Abstract][Full Text] [Related]
20. Hydroxyurea versus busulfan in the treatment of chronic myelogenous leukemia.
Rushing D; Goldman A; Gibbs G; Howe R; Kennedy BJ
Am J Clin Oncol; 1982 Jun; 5(3):307-13. PubMed ID: 6952759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
